AR and prostate carcinoma: Increased surrounding infiltrating bone marrow mesenchymal stem cells directly suppress AR expression through CCL5/HIF2α pathway and CCL5 from the bone microenvironment has been shown to promote the growth of prostate cancer bone metastases [25].